Amyloidosis

Landscape Report →
108 active trials
13 Phase 3
68 recruiting
75 sponsors
Updated daily from ClinicalTrials.gov
Top sponsors Alnylam Pharmaceuticals (8) Fondazione IRCCS Policlinico San Matteo di Pavia (6) Mayo Clinic (5) Alexion Pharmaceuticals, Inc. (4) University of Texas Southwestern Medical Center (4)